The ashwagandha paradox: a mixed-methods analysis of regulatory gaps, deceptive vendors and safety risks in the European online market
Bálint Márk Domián(University of Pecs), Róbert György Vida(University of Pecs), J. Schmidt(Institute of Biochemistry), András Fittler(University of Pecs), Viktoria Pusztai(University of Pecs), Bence Jónás(University of Pecs), Áron Solt Horváth(University of Pecs), László Márk(University of Pecs), Luca Kalocsa(University of Pecs), Ádám Sándor Nagy(University of Pecs), Júlia Sokoray-Varga(University of Pecs), Boglárka Csupor‐Löffler(University of Pecs), Elvira Fábián(University of Pecs), Amir Reza Ashraf(University of Pecs)
Cited by 0
Related Papers
CBD, a precursor of THC in e-cigarettes
|Scientific Reports|2021|83
The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials
|Pharmaceuticals|2022|41
The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations
|Scientific Reports|2020|39
Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases
|JAMA Network Open|2024|38
Search Engines and Generative Artificial Intelligence Integration: Public Health Risks and Recommendations to Safeguard Consumers Online
|JMIR Public Health and Surveillance|2024|27